RTW INVESTMENTS, LP

Q2 2023 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
6/30/2023
Date filed
8/14/2023
Form type
13F-HR
Num holdings
62
Total value ($000)
$5,252,749
Net value change ($000)
+450,596 (9.4%)
New positions
10
Sold out positions
8
Turnover %
14.0%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 5/15/2023 Next filing: 11/14/2023 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
BRKR 125,164 133.7%
Horizon Therapeutics Public Ltd Co 102,850 NEW
IMCR 82,204 29.4%
ACAD 79,178 51.0%
RARE 78,070 45.6%
AXSM 74,665 32.0%
AVDL 59,643 113.4%
ISRG 58,130 NEW
MDGL 51,181 NEW
RCKT 48,464 16.0%
Top Reduces (Value $000, Stocks/ETFs)
Prometheus Biosciences, Inc. -351,162 -100.0%
OBIO -60,825 -60.7%
PTCT -49,344 -14.4%
VTYX -46,528 -100.0%
MASI -30,015 -10.8%
RNAM -23,853 -24.3%
NTRA -17,917 -12.4%
ALNY -17,473 -5.2%
ILMN -16,954 -19.4%
TMO -15,858 -9.5%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 RTW MASTER FUND, LTD. 028-16671
2 RTW Innovation Master Fund Ltd. 028-19525
3 RTW Biotech Opportunities Ltd 028-19571